CGON
CG Oncology·NASDAQ
--
--(--)
--
--(--)
4.20 / 10
Netural
Technical analysis composite: 4.2/10, portraying mixed technical signals. Strengths manifested in RSI Overbought confront weaknesses evidenced by MACD Death Cross, Marubozu White, and Dark Cloud Cover. Technical inference: neutral with watchful bias.
Analysis Checks(1/4)
RSI Overbought
Score5.73/10
Win Rate61.11%
Hist. Signals18
Avg Return-1.07%
Score5.73/10
Win Rate61.11%
Hist. Signals18
Avg Return-1.07%
Dark Cloud Cover
Score4.87/10
Win Rate50.00%
Hist. Signals4
Avg Return7.56%
Score4.87/10
Win Rate50.00%
Hist. Signals4
Avg Return7.56%
MACD Death Cross
Score4.37/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.47%
Score4.37/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.47%
Marubozu White
Score1.83/10
Win Rate20.00%
Hist. Signals5
Avg Return4.17%
Score1.83/10
Win Rate20.00%
Hist. Signals5
Avg Return4.17%
RSI Overbought
Score5.73/10
Win Rate61.11%
Hist. Signals18
Avg Return-1.07%
Score5.73/10
Win Rate61.11%
Hist. Signals18
Avg Return-1.07%
MACD Death Cross
Score4.37/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.47%
Score4.37/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.47%
Dark Cloud Cover
Score4.87/10
Win Rate50.00%
Hist. Signals4
Avg Return7.56%
Score4.87/10
Win Rate50.00%
Hist. Signals4
Avg Return7.56%
Marubozu White
Score1.83/10
Win Rate20.00%
Hist. Signals5
Avg Return4.17%
Score1.83/10
Win Rate20.00%
Hist. Signals5
Avg Return4.17%
Technical Analysis of CGON?
- CGON presents a Netural setup with a Technical Score of 4.20/10. Key technical indicators highlight an RSI of 50.15 and a MACD of -1.82, with the trend anchored by the 50-Day SMA at 46.22. Traders should monitor key support at 47.74 and resistance at 51.42.
